Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

LEVOPHED® NOREPINEPHRINE BITARTRATE, Vial N+ U.S. Physician Prescribing Information Principal Display Panel (norepinephrine bitartrate injection, USP)

PRINCIPAL DISPLAY PANEL - 4 mL Vial Label

NDC 0409-3375-25
Rx only

4 mL Fill in 5 mL Vial
Single dose Fliptop Vial

Levophed™
norepinephrine bitartrate inj., USP

4 mg/4 mL (1 mg/mL)

FOR IV INFUSION ONLY
Warning: Contains Sulfites.

Mfd. by Hospira, Inc., Lake Forest, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 4 mL Vial Label

PRINCIPAL DISPLAY PANEL - 4 mL Vial Carton

NDC 0409-3375-25
Rx only

STERILE INJECTION
4 mL
10 Single dose Fliptop Vials

Levophed™ norepinephrine bitartrate injection, USP

4 mg/4 mL (1 mg/mL)

FOR INTRAVENOUS INFUSION ONLY
Warning: Contains Sulfites.

Warning: This is a potent drug. Dosage should be controlled by frequent determination of blood
pressure. Do not leave patient unattended during administration. Avoid extravasation. Read package
insert carefully.
DILUTE BEFORE USE. DISCARD UNUSED PORTION. PROTECT FROM LIGHT.

PRINCIPAL DISPLAY PANEL - 4 mL Vial Carton
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event